Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial.

Kahn RS, Fleischhacker WW, Boter H, Davidson M, Vergouwe Y, Keet IP, Gheorghe MD, Rybakowski JK, Galderisi S, Libiger J, Hummer M, Dollfus S, López-Ibor JJ, Hranov LG, Gaebel W, Peuskens J, Lindefors N, Riecher-Rössler A, Grobbee DE; EUFEST study group..

Lancet. 2008 Mar 29;371(9618):1085-97. doi: 10.1016/S0140-6736(08)60486-9.

PMID:
18374841
2.

The costs of schizophrenia.

McEvoy JP.

J Clin Psychiatry. 2007;68 Suppl 14:4-7. Review.

3.

Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: prospective data from phase 1.

Meyer JM, Davis VG, Goff DC, McEvoy JP, Nasrallah HA, Davis SM, Rosenheck RA, Daumit GL, Hsiao J, Swartz MS, Stroup TS, Lieberman JA.

Schizophr Res. 2008 Apr;101(1-3):273-86. doi: 10.1016/j.schres.2007.12.487.

4.

Adverse effects of antipsychotics as outcome measures.

Hamer S, Haddad PM.

Br J Psychiatry Suppl. 2007 Aug;50:s64-70. Review.

PMID:
18019047
5.

Adding or switching antipsychotic medications in treatment-refractory schizophrenia.

Kreyenbuhl J, Marcus SC, West JC, Wilk J, Olfson M.

Psychiatr Serv. 2007 Jul;58(7):983-90.

6.
7.

Effectiveness of olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia after discontinuing perphenazine: a CATIE study.

Stroup TS, Lieberman JA, McEvoy JP, Swartz MS, Davis SM, Capuano GA, Rosenheck RA, Keefe RS, Miller AL, Belz I, Hsiao JK; CATIE Investigators..

Am J Psychiatry. 2007 Mar;164(3):415-27.

PMID:
17329466
8.

Effectiveness of switching antipsychotic medications.

Essock SM, Covell NH, Davis SM, Stroup TS, Rosenheck RA, Lieberman JA.

Am J Psychiatry. 2006 Dec;163(12):2090-5.

PMID:
17151159
9.

Cost-effectiveness of olanzapine as first-line treatment for schizophrenia: results from a randomized, open-label, 1-year trial.

Tunis SL, Faries DE, Nyhuis AW, Kinon BJ, Ascher-Svanum H, Aquila R.

Value Health. 2006 Mar-Apr;9(2):77-89.

10.

Effectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychotic.

Stroup TS, Lieberman JA, McEvoy JP, Swartz MS, Davis SM, Rosenheck RA, Perkins DO, Keefe RS, Davis CE, Severe J, Hsiao JK; CATIE Investigators..

Am J Psychiatry. 2006 Apr;163(4):611-22.

PMID:
16585435
12.

Switching antipsychotics: an updated review with a focus on quetiapine.

Weiden PJ.

J Psychopharmacol. 2006 Jan;20(1):104-18. Review.

PMID:
16204323
13.

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.

Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, Keefe RS, Davis SM, Davis CE, Lebowitz BD, Severe J, Hsiao JK; Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators..

N Engl J Med. 2005 Sep 22;353(12):1209-23. Erratum in: N Engl J Med. 2010 Sep 9;363(11):1092-3.

14.

Effect of switching antipsychotics on antiparkinsonian medication use in schizophrenia: population-based study.

Park S, Ross-Degnan D, Adams AS, Sabin J, Kanavos P, Soumerai SB.

Br J Psychiatry. 2005 Aug;187:137-42.

15.

Advanced statistics: the propensity score--a method for estimating treatment effect in observational research.

Newgard CD, Hedges JR, Arthur M, Mullins RJ.

Acad Emerg Med. 2004 Sep;11(9):953-61.

16.

Weight change after an atypical antipsychotic switch.

Ried LD, Renner BT, Bengtson MA, Wilcox BM, Acholonu WW Jr.

Ann Pharmacother. 2003 Oct;37(10):1381-6.

PMID:
14519048
17.
18.

Effectiveness of switching to ziprasidone for stable but symptomatic outpatients with schizophrenia.

Weiden PJ, Simpson GM, Potkin SG, O'Sullivan RL.

J Clin Psychiatry. 2003 May;64(5):580-8.

PMID:
12755663
19.

Evidence for the effectiveness of olanzapine among patients nonresponsive and/or intolerant to risperidone.

Dossenbach MR, Kratky P, Schneidman M, Grundy SL, Metcalfe S, Tollefson GD, Belmaker RH.

J Clin Psychiatry. 2001;62 Suppl 2:28-34.

20.
Items per page

Supplemental Content

Support Center